Contact
Please use this form to send email to PR contact of this press release:
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
TO:
Please use this form to send email to PR contact of this press release:
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
TO: